A carbocisteine ​​oral preparation and preparation method thereof

By using excipients such as hydroxyethyl cellulose or xanthan gum in carboxystein oral preparations, combining flavoring agents and preservatives to adjust the pH value, the problems of carboxystein are solved and stability is achieved Improvement and reduce safety, avoiding the use of high-cost cyclodextrins.

CN115137693BActive Publication Date: 2024-12-03CHENGDU BRILLIANT PHARMA CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110352428.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-03-31
Publication Date
2024-12-03
Estimated Expiration
2041-03-31

AI Technical Summary

Technical Problem

As a hard-to-soluble drug, carboxystein is difficult to make stable oral preparations, especially solutions, which are easy to precipitate and increase drug impurities, resulting in safety risks. In the prior art, the dosage of cyclodextrin is too large and the cost is high, which cannot be met. Safety requirements.

Method used

Using a combination of carboxystein, ethyl cellulose or xanthan gum, it is prepared through specific proportions of raw and auxiliary materials, combined with flavoring agents, preservatives and flavors, adjust the pH value, and form a stable oral preparation, reducing the storage of drugs and Risk of use.

Benefits of technology

The stability of carboxystam oral preparations has been improved, which reduces the safety risks during storage and use, and avoids the use of high-cost cyclodextrin, providing a safe and economical form of drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003002504940000011
    Figure BDA0003002504940000011
  • Figure BDA0003002504940000021
    Figure BDA0003002504940000021
  • Figure BDA0003002504940000022
    Figure BDA0003002504940000022
Patent Text Reader

Abstract

The present invention provides a carbocysteine ​​oral preparation and a preparation method thereof, belonging to the technical field of pharmaceutical preparations. The carbocysteine ​​oral preparation is an oral preparation prepared from raw materials and auxiliary materials including the following weight percentages: 50-75 parts of carbocysteine, 3-15 parts of hydroxyethylcellulose; or 50-75 parts of carbocysteine, 1-15 parts of xanthan gum. The present invention adopts specific raw materials to prepare a carbocysteine ​​oral preparation with excellent stability, reduces its safety risk during storage and use, and has good application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to a carbocysteine ​​oral preparation and a preparation method thereof. Background Art

[0002] Carbocisteine ​​is a mucus thinner mainly used to treat thick sputum, expectoration or dyspnea caused by chronic bronchitis, chronic obstructive pulmonary disease (COPD) and bronchial asthma, as well as pulmonary ventilation insufficiency caused by sputum blocking the trachea.

[0003]

[0004] Carbocysteine ​​is a white crystalline powder, odorless. It belongs to a poorly soluble drug, slightly soluble in hot water, very slightly soluble in water, and insoluble in ethanol or acetone. Therefore, carbocysteine ​​is not easy to be made into oral preparations, particularly solutions. After making oral preparations, carbocysteine ​​is unstable and easily precipitates, which increases drug impurities and causes drug safety risks to increase. Therefore, when carbocysteine ​​is made into oral preparations, how to improve its stability is the key to research.

[0005] Patent CN109498555A provides a carbocisteine ​​oral solution, which uses cyclodextrin to increase the water solubility of the drug, improve the stability of the drug, promote drug absorption, and prevent the interaction between the drug and excipients. However, the amount of cyclodextrin used in this patent is large and the cost is high. The maximum daily dose of cyclodextrin is about 10.8g, which obviously exceeds the "maximum daily average oral dose of alpha cyclodextrin is 1700mg / day" stipulated in the CDE excipient database.

[0006] It is of great significance to find a new oral preparation of carbocysteine ​​with good stability and safe medication. Summary of the invention

[0007] In order to solve the above problems, the present invention provides a carbocysteine ​​oral preparation and a preparation method thereof.

[0008] The present invention provides a carbocysteine ​​oral preparation, which is an oral preparation prepared from raw and auxiliary materials including the following weight percentages: 50-75 parts of carbocysteine ​​and 3-15 parts of hydroxyethyl cellulose;

[0009] Or 50-75 parts of carbocysteine ​​and 1-15 parts of xanthan gum.

[0010] Furthermore, the aforementioned oral preparation of carbocysteine ​​is an oral preparation prepared from raw materials and auxiliary materials comprising the following weight percentages: 50 parts of carbocysteine ​​and 3.6 to 11 parts of hydroxyethylcellulose;

[0011] Or 50 parts of carbocysteine ​​and 2.5-5 parts of xanthan gum;

[0012] Preferably,

[0013] The oral preparation is prepared from raw and auxiliary materials including the following weight percentages: 50 parts of carbocysteine ​​and 5.0 parts of hydroxyethyl cellulose;

[0014] Or 50 parts of carbocysteine ​​and 2.5 parts of xanthan gum.

[0015] Furthermore, the auxiliary materials also include 2 to 20 parts of flavoring agents and 1 to 10 parts of preservatives;

[0016] Preferably, the flavoring agent is 1 to 10 parts of saccharin sodium and 1 to 10 parts of flavor.

[0017] Furthermore, the aforementioned oral preparation of carbocysteine ​​is an oral preparation prepared from the following raw materials and auxiliary materials in weight percentage: 50-75 parts of carbocysteine, 3-15 parts of hydroxyethylcellulose, 1-10 parts of saccharin sodium, 1-10 parts of flavor, and 1-10 parts of preservative;

[0018] Or 50-75 parts of carbocysteine, 1-15 parts of xanthan gum, 1-10 parts of saccharin sodium, 1-10 parts of flavor, 1-10 parts of preservative;

[0019] Preferably, it is an oral preparation prepared from the following raw materials and auxiliary materials in the following weight percentages: 50 parts of carbocysteine, 3.6-11 parts of hydroxyethylcellulose, 5 parts of saccharin sodium, 3 parts of flavor, and 2 parts of preservative;

[0020] Or 50 parts of carbocysteine, 2.5-5 parts of xanthan gum, 5 parts of saccharin sodium, 3 parts of flavors, and 2 parts of preservatives.

[0021] Furthermore, the aforementioned carbocysteine ​​oral preparation is an oral preparation prepared from the following raw materials and auxiliary materials in the following weight percentages: 50 parts of carbocysteine, 5 parts of hydroxyethylcellulose, 5 parts of saccharin sodium, 3 parts of flavor, and 2 parts of preservative;

[0022] Or 50 parts of carbocysteine, 2.5 parts of xanthan gum, 5 parts of saccharin sodium, 3 parts of flavors, and 2 parts of preservatives.

[0023] Furthermore, each 1 ml of carbocisteine ​​oral preparation contains:

[0024]

[0025] Alternatively, each 1 ml of carbocisteine ​​oral preparation contains:

[0026]

[0027] Furthermore, each 1 ml of carbocisteine ​​oral preparation contains:

[0028]

[0029]

[0030] Alternatively, each 1 ml of carbocisteine ​​oral preparation contains:

[0031]

[0032] Furthermore, the preservative is methylparaben; and / or the flavor is strawberry flavor, pomegranate flavor, orange flavor, or vanilla flavor; preferably, the flavor is strawberry flavor.

[0033] Furthermore, the pH of the carbocysteine ​​oral preparation is 5.5 to 7.0.

[0034] The present invention also provides a method for preparing the aforementioned carbocysteine ​​oral preparation, which comprises the following steps:

[0035] Dissolve the aforementioned raw materials and auxiliary materials in water and adjust the pH to obtain the product.

[0036] The invention adopts specific raw materials and auxiliary materials to prepare the carbocysteine ​​oral preparation with excellent stability, reduces the safety risk during storage and use, and has good application prospects.

[0037] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.

[0038] The above contents of the present invention are further described in detail below through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. DETAILED DESCRIPTION

[0039] The raw materials and equipment used in the specific embodiments of the present invention are all known products and are obtained by purchasing commercially available products.

[0040] Example 1. Preparation of Carbocisteine ​​Oral Preparation of the Present Invention

[0041] Prescription composition:

[0042]

[0043]

[0044] Preparation method:

[0045] (1) Place methylparaben in about 40% volume purified water, heat to dissolve and set aside to obtain solution ①;

[0046] (2) Place hydroxyethyl cellulose in about 40% volume purified water, dissolve it and set aside to obtain solution ②;

[0047] (3) Weigh the API and add a certain amount of NaOH solution, stir to dissolve and set aside to obtain solution ③;

[0048] (4) After mixing solutions ①, ②, and ③, add saccharin sodium and essence, stir until dissolved, adjust the pH, and fix the volume to obtain the oral carbocysteine ​​preparation of the present invention.

[0049] Example 2, Preparation of Carbocisteine ​​Oral Preparation of the Present Invention

[0050] Prescription composition:

[0051] Components Weight ratio mg / ml API 50 Saccharin Sodium 5.0 Methylparaben 2.0 Hydroxyethylcellulose 5.0 Fragrance(Orange) 3 NaOH Adjust pH to 5.5-7.0 Purified water Dilute to 1 ml

[0052] Preparation method:

[0053] (1) Place methylparaben in about 40% volume purified water, heat to dissolve and set aside to obtain solution ①;

[0054] (2) Place hydroxyethyl cellulose in about 40% volume purified water, dissolve it and set aside to obtain solution ②;

[0055] (3) Weigh the API and add a certain amount of NaOH solution, stir to dissolve and set aside to obtain solution ③;

[0056] (4) After mixing solutions ①, ②, and ③, add saccharin sodium and essence, stir until dissolved, adjust the pH, and fix the volume to obtain the oral carbocysteine ​​preparation of the present invention.

[0057] Example 3: Preparation of Carbocisteine ​​Oral Preparation of the Present Invention

[0058] Prescription composition:

[0059] Components Weight ratio mg / ml API 50 Saccharin Sodium 5.0 Methylparaben 2.0 Hydroxyethylcellulose 5.0 Flavor (vanilla) 3 NaOH Adjust pH to 5.5-7.0 Purified water Dilute to 1 ml

[0060] Preparation method:

[0061] (1) Place methylparaben in about 40% volume purified water, heat to dissolve and set aside to obtain solution ①;

[0062] (2) Place hydroxyethyl cellulose in about 40% volume purified water, dissolve it and set aside to obtain solution ②;

[0063] (3) Weigh the API and add a certain amount of NaOH solution, stir to dissolve and set aside to obtain solution ③;

[0064] (4) After mixing solutions ①, ②, and ③, add saccharin sodium and essence, stir until dissolved, adjust the pH, and fix the volume to obtain the oral carbocysteine ​​preparation of the present invention.

[0065] Example 4. Preparation of Carbocisteine ​​Oral Preparation of the Present Invention

[0066] Prescription composition:

[0067] Components Weight ratio mg / ml API 50 Saccharin Sodium 5.0 Methylparaben 2.0 Hydroxyethylcellulose 5.0 Flavor(Strawberry) 3 NaOH Adjust pH to 5.5-7.0 Purified water Dilute to 1 ml

[0068] Preparation method:

[0069] (1) Methylparaben is placed in about 30% volume purified water, heated to dissolve, and then sodium saccharin is added. After complete dissolution, about 55% volume purified water is added, and then hydroxyethylcellulose is added and stirred until complete dissolution to obtain solution ①;

[0070] (2) Weigh the API and add a certain amount of NaOH solution, stir to dissolve and set aside to obtain solution ②;

[0071] (3) After mixing solutions ① and ②, add essence, stir until dissolved, adjust the pH, and fix the volume to obtain the oral carbocysteine ​​preparation of the present invention.

[0072] Example 5. Stability test of the oral carbocisteine ​​preparations prepared in Examples 1 to 4

[0073] Detection method:

[0074] Column: Welch Ultimate AQ-C18, 4.6×250 mm, 5 μm;

[0075] Column temperature: 30℃; detection wavelength: 215nm; injection volume: 20μl; flow rate: 1ml / min; solvent: water; mobile phase A: a mixed solution of 45mM NaH2PO4+5mM sodium decane sulfonate, with the pH adjusted to 2.5 with phosphoric acid; mobile phase B: methanol; test sample concentration: 2mg / ml. The gradient elution procedure is as follows:

[0076]

[0077]

[0078] Test results: The stability test results of the carbocisteine ​​oral preparations prepared in Examples 1 to 4 after being stored at 30° C. for 3 months and 40° C. for 30 days are shown in Tables 1 to 4.

[0079] Table 1. Stability test results of carbocisteine ​​oral preparations prepared in Example 1

[0080]

[0081] Table 2. Stability test results of carbocisteine ​​oral preparations prepared in Example 2

[0082]

[0083] Table 3. Stability test results of carbocisteine ​​oral preparations prepared in Example 3

[0084]

[0085] Table 4. Stability test results of carbocisteine ​​oral preparations prepared in Example 4

[0086]

[0087] From the stability data of Examples 1 to 4, it can be seen that in terms of the number of impurities and the total content of impurities, the stability of the preparation samples containing flavors is in the order of strawberry>vanilla>pomegranate>orange. It can be seen that the oral preparation of carbocisteine ​​prepared with strawberry flavor has the best stability. And from Example 4, it can be seen that after the preparation samples are filled with nitrogen, the content of unknown impurities is further reduced.

[0088] Example 6: Study on the stability of the oral carbocysteine ​​preparation of the present invention under different storage environments

[0089] Prescription composition

[0090] Components Weight ratio mg / ml API 50 Saccharin Sodium 5.0 Methylparaben 2.0 Hydroxyethylcellulose 5.0 Flavor(Strawberry) 3 NaOH Adjust pH to 5.5-7.0 Purified water Dilute to 1 ml

[0091] Preparation method: methylparaben is placed in about 30% volume of purified water, heated to dissolve, then about 38% volume of purified water is added, and then hydroxyethylcellulose is added and stirred until completely dissolved; API, saccharin sodium, and flavor are added, stirred and evenly dispersed, and then an appropriate amount of NaOH solution is added, the pH is adjusted, and the volume is constant to obtain the carbocisteine ​​oral preparation of the present invention.

[0092] The above samples were placed in a water bath at 50°C and 60°C for different time periods. The stability of the oral preparation was then tested according to the method described in Example 5. The results are shown in Table 5.

[0093] Table 5. Stability test results of the carbocisteine ​​oral preparation of the present invention under different storage environments

[0094]

[0095] From the stability data of Example 6, it can be seen that the number and total amount of impurities in the oral carbocysteine ​​preparation of the present invention do not change significantly within 8 hours at 50°C and within 3 hours at 60°C, indicating that the oral carbocysteine ​​preparation of the present invention has good stability.

[0096] Example 7: Effects of different amounts of raw materials and auxiliary materials on the stability of oral carbocysteine ​​preparations

[0097] Prescription composition

[0098]

[0099] Preparation method: Place methylparaben in about 30% volume of purified water, heat to dissolve, add about 38% volume of purified water, then add hydroxyethyl cellulose and stir until completely dissolved; add API, saccharin sodium, and flavor, stir to evenly disperse, add appropriate amount of NaOH solution, adjust pH, and make up to obtain carbocysteine ​​oral preparation.

[0100] The stability of the oral preparations in each group was tested according to the method described in Example 5. The results are shown in Table 6.

[0101] Table 6. Stability test results of carbocisteine ​​oral preparations prepared with different amounts of raw materials and excipients

[0102]

[0103] From the stability data of Example 7, it can be seen that when the dosage of hydroxyethylcellulose is in the range of 3.6 to 11 mg / ml, the obtained carbocysteine ​​oral preparations have good stability.

[0104] Example 8: Effects of different raw materials and auxiliary materials on the stability of oral carbocysteine ​​preparations

[0105] Prescription composition

[0106]

[0107] Preparation method: Place methylparaben in about 30% volume of purified water, heat to dissolve, add about 38% volume of purified water, then add xanthan gum, hydroxyethyl cellulose, hydroxypropyl methylcellulose or starch and stir until completely dissolved; add API, saccharin sodium and flavor, stir to evenly disperse, add appropriate amount of NaOH solution, adjust pH and make up to obtain carbocisteine ​​oral preparation.

[0108] The stability of the oral preparations in the above groups was tested according to the method described in Example 5. The results are shown in Table 7.

[0109] Table 7. Stability test results of oral carbocysteine ​​preparations prepared with different raw materials and excipients

[0110]

[0111] From the stability data of Example 8, it can be seen that different excipients have a great influence on the stability of carbocysteine ​​oral preparations, among which the carbocysteine ​​oral preparations prepared using xanthan gum and hydroxyethyl cellulose have excellent stability, which is significantly better than hydroxypropyl methylcellulose and starch.

[0112] In summary, the present invention adopts specific raw materials and auxiliary materials to prepare a carbocysteine ​​oral preparation with excellent stability, reduces the safety risk during storage and use, and has good application prospects.

Claims

1. A carbocisteine ​​oral preparation, characterized in that: It is an oral preparation made of raw materials and auxiliary materials in the following weight percentages: 50 parts of carbocysteine, 3.6-11 parts of hydroxyethylcellulose, 5 parts of saccharin sodium, 3 parts of flavor, 2 parts of preservative; Or 50 parts of carbocysteine, 2.5-5 parts of xanthan gum, 5 parts of saccharin sodium, 3 parts of flavor, 2 parts of preservative; The preservative is methylparaben; the flavor is strawberry flavor or vanilla flavor; The pH value of the oral carbocysteine ​​preparation is 5.5 to 7.

0.

2. The carbocisteine ​​oral preparation according to claim 1, characterized in that: The oral preparation is prepared from the following raw materials and auxiliary materials in weight percentage: 50 parts of carbocysteine, 5 parts of hydroxyethylcellulose, 5 parts of saccharin sodium, 3 parts of flavor, and 2 parts of preservative; Or 50 parts of carbocysteine, 2.5 parts of xanthan gum, 5 parts of saccharin sodium, 3 parts of flavors, and 2 parts of preservatives.

3. The carbocisteine ​​oral preparation according to claim 1, characterized in that: Each 1 ml of carbocisteine ​​oral preparation contains: Alternatively, each 1 ml of carbocisteine ​​oral preparation contains:

4. The carbocisteine ​​oral preparation according to claim 3, characterized in that: Each 1 ml of carbocisteine ​​oral preparation contains: Alternatively, each 1 ml of carbocisteine ​​oral preparation contains:

5. The oral carbocisteine ​​preparation according to any one of claims 1 to 4, characterized in that: The flavor is strawberry flavor.

6. A method for preparing the oral carbocysteine ​​preparation according to any one of claims 1 to 5, characterized in that: It includes the following steps: The raw and auxiliary materials according to any one of claims 1 to 5 are dissolved in water and the pH is adjusted to obtain the product.